MCID: TYP003
MIFTS: 15

Type I Ehlers-Danlos Syndrome

Categories: Blood diseases, Bone diseases, Fetal diseases, Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Type I Ehlers-Danlos Syndrome

MalaCards integrated aliases for Type I Ehlers-Danlos Syndrome:

Name: Type I Ehlers-Danlos Syndrome 12 15
Ehlers-Danlos Syndrome Type 1 45 74
Ehlers-Danlos Syndrome, Type 1 12

Classifications:



External Ids:

Disease Ontology 12 DOID:14720
MeSH 45 C536194
NCIt 51 C125696
SNOMED-CT 69 83470009
UMLS 74 C0268335

Summaries for Type I Ehlers-Danlos Syndrome

MalaCards based summary : Type I Ehlers-Danlos Syndrome, also known as ehlers-danlos syndrome type 1, is related to ehlers-danlos syndrome, classic type, 1 and ehlers-danlos syndrome. An important gene associated with Type I Ehlers-Danlos Syndrome is COL1A2 (Collagen Type I Alpha 2 Chain). The drugs Clindamycin and Rifampicin have been mentioned in the context of this disorder.

Related Diseases for Type I Ehlers-Danlos Syndrome

Diseases in the Ehlers-Danlos Syndrome family:

Ehlers-Danlos Syndrome, Type V Type I Ehlers-Danlos Syndrome
Autosomal Recessive Type Iv Ehlers-Danlos Syndrome Ehlers-Danlos Syndrome Type 7b

Diseases related to Type I Ehlers-Danlos Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 ehlers-danlos syndrome, classic type, 1 12.0
2 ehlers-danlos syndrome 10.1

Symptoms & Phenotypes for Type I Ehlers-Danlos Syndrome

Drugs & Therapeutics for Type I Ehlers-Danlos Syndrome

Drugs for Type I Ehlers-Danlos Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
2
Rifampicin Approved Phase 3 13292-46-1 5381226 5458213
3 Anti-Bacterial Agents Phase 3
4 Anti-Infective Agents Phase 3
5 Antibiotics, Antitubercular Phase 3
6 Antitubercular Agents Phase 3
7 Clindamycin palmitate Phase 3
8 Clindamycin phosphate Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter Completed NCT00286104 Phase 3

Search NIH Clinical Center for Type I Ehlers-Danlos Syndrome

Cochrane evidence based reviews: ehlers-danlos syndrome type 1

Genetic Tests for Type I Ehlers-Danlos Syndrome

Anatomical Context for Type I Ehlers-Danlos Syndrome

Publications for Type I Ehlers-Danlos Syndrome

Variations for Type I Ehlers-Danlos Syndrome

Expression for Type I Ehlers-Danlos Syndrome

Search GEO for disease gene expression data for Type I Ehlers-Danlos Syndrome.

Pathways for Type I Ehlers-Danlos Syndrome

GO Terms for Type I Ehlers-Danlos Syndrome

Sources for Type I Ehlers-Danlos Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....